Literature DB >> 8019250

Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.

J E Macgregor1, M K Campbell, E M Mann, K Y Swanson.   

Abstract

OBJECTIVE: To assess the effect of screening for cervical intraepithelial neoplasia on the incidence of and mortality from invasive squamous cell carcinoma of cervix in north east Scotland and to discover why cases of invasive cancer still occur.
DESIGN: (a) Analysis of data on cases of cervical intraepithelial neoplasia obtained from the cytology data bank; (b) analysis of data on 612 women presenting with invasive squamous cancer during 1968-91, obtained from cancer registry and hospital records; (c) analysis of death rates obtained from the registrar general's (Scotland) annual reports, the Information Services Division of the Home and Health Department (Scotland), and local records for 1974-91; (d) case-control studies on 282 cases of invasive cancer and 108 deaths which occurred in 1982-91. Cases were matched with two controls both for age and for having a negative smear test result at the time of presentation of the case.
SETTING: North east Scotland (Grampian region, Orkney, and Shetland).
SUBJECTS: Women (n = 306,608) who had had cervical smear tests between 1960 and 1991.
RESULTS: There had been a substantial increase in cases of cervical intraepithelial neoplasia grade III since 1982. The incidence of invasive cancer has fallen since the start of screening in 1960, the fall occurring mainly in the well screened age group 40-69 years. There was a rise in women aged under 40 and over 70. Women with invasive disease seen between 1982 and 1991 mostly presented at stage I. Of these, half were unscreened, one third were poorly screened, 11% were found in retrospect to have had abnormal cells, 3% had recurrence of disease after treatment for cervical intraepithelial neoplasia grade III, and 3% were lost to follow up. Death rates had fallen, most noticeably in women aged 45-64, who had had the opportunity to be screened and rescreened. There was a disturbing rise in deaths among women under 45. Most deaths (65%) occurred in unscreened women. Case-control studies showed that the longer the time and absence of a smear test before presentation the higher was the risk of invasive cancer and of death.
CONCLUSIONS: Screening has been effective in reducing the incidence of and mortality from cervical cancer in north east Scotland. Most cases and deaths occurred in unscreened women or in those who had had few smears at long intervals. An increase in cases of cervical intraepithelial neoplasia grade III in women screened for the first time occurred during 1982-91.

Entities:  

Mesh:

Year:  1994        PMID: 8019250      PMCID: PMC2540391          DOI: 10.1136/bmj.308.6941.1407

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Predicting mortality from cervical cancer after negative smear test results.

Authors:  G J van Oortmarssen; J D Habbema; M van Ballegooijen
Journal:  BMJ       Date:  1992-08-22

2.  Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome.

Authors:  A J Kirby; D J Spiegelhalter; N E Day; L Fenton; K Swanson; E M Mann; J E Macgregor
Journal:  Lancet       Date:  1992-04-04       Impact factor: 79.321

3.  Cancer of the uterine cervix: some factors influencing survival rates.

Authors:  J G LAWSON
Journal:  J Obstet Gynaecol Br Emp       Date:  1956-12

4.  Detection of Cervical Carcinoma in the General Population.

Authors:  J E Macgregor; D Baird
Journal:  Br Med J       Date:  1963-06-22

5.  Observer variability in histopathological reporting of cervical biopsy specimens.

Authors:  A J Robertson; J M Anderson; J S Beck; R A Burnett; S R Howatson; F D Lee; A M Lessells; K M McLaren; S M Moss; J G Simpson
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

6.  Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.

Authors:  E Lăără; N E Day; M Hakama
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

Review 7.  Quality control in cervical cytology.

Authors:  O A Husain; E B Butler; D M Evans; J E Macgregor; R Yule
Journal:  J Clin Pathol       Date:  1974-12       Impact factor: 3.411

8.  Rationale for stopping cervical screening in women over 50.

Authors:  W J Van Wijngaarden; I D Duncan
Journal:  BMJ       Date:  1993-04-10

9.  Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy.

Authors:  P Cooper; A J Kirby; D J Spiegelhalter; A L Whitehead; A Patterson
Journal:  Cytopathology       Date:  1992       Impact factor: 2.073

10.  Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.

Authors:  G H Anderson; D A Boyes; J L Benedet; J C Le Riche; J P Matisic; K C Suen; A J Worth; A Millner; O M Bennett
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02
View more
  24 in total

Review 1.  Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour.

Authors:  F Fylan
Journal:  Br J Gen Pract       Date:  1998-08       Impact factor: 5.386

Review 2.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

3.  Balancing proactive and reactive care.

Authors:  J C Gillies; A G Baird; E M Gillies
Journal:  Occas Pap R Coll Gen Pract       Date:  1995-09

4.  Increase in incidence of invasive cervical cancer.

Authors:  S Ciatto; S Cecchini; M Zappa; A Biggeri
Journal:  BMJ       Date:  1994-10-08

5.  Management of mild dyskaryosis.

Authors:  H Merriman; N Charnock; W Gray; N Hallam
Journal:  BMJ       Date:  1994-08-06

6.  Management of women with mild dyskaryosis. Cytological surveillance avoids overtreatment.

Authors:  M I Shafi
Journal:  BMJ       Date:  1994-09-03

7.  Management of women with smears showing mild dyskaryosis.

Authors:  R Hammond
Journal:  BMJ       Date:  1994-05-28

8.  Management of cervical dyskaryosis. No easy answer.

Authors:  A E Raffle; E F Mackenzie
Journal:  BMJ       Date:  1994-07-23

9.  Screening for cervical intraepithelial neoplasia.

Authors:  S M Crawford
Journal:  BMJ       Date:  1994-07-16

Review 10.  [What does HPV vaccination mean for gynecologic cancer screening?].

Authors:  K U Petry
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.